Stage-Specific Outcomes of Patients With Uterine Leiomyosarcoma: A Comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on Cancer Staging Systems

This publication has 43 references indexed in Scilit:

• Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)
  European Journal Of Cancer, 2008
• A Nomogram Predicting 10-Year Life Expectancy in Candidates for Radical Prostatectomy or Radiotherapy for Prostate Cancer
  Journal of Clinical Oncology, 2007
• Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia
  Blood, 2007
• Multi-Institutional Validation of a New Renal Cancer–Specific Survival Nomogram
  Journal of Clinical Oncology, 2007
• Are Nomograms Better Than Currently Available Stage Groupings for Bladder Cancer?
  Journal of Clinical Oncology, 2006
• Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma
  Cancer, 2005
• A new measure of prognostic separation in survival data
  Statistics in Medicine, 2004
• Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma
  Cancer, 2000
• Uterine Leiomyosarcoma and Endometrial Stromal Sarcoma: Lymph Node Metastases and Sites of Recurrence
  Gynecologic Oncology, 1993
• The Will Rogers Phenomenon
  New England Journal of Medicine, 1985